Patrick Tony Jasinski

Dr. Patrick Tony Jasinski

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2016 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
NLNicos Labropoulos
Nicos Labropoulos
PJPatrick Tony Jasinski
Patrick Tony Jasinski
DADemetri Adrahtas
Demetri Adrahtas
AGAntonios P. Gasparis
Antonios P. Gasparis
MMMark H. Meissner
Mark H. Meissner
Pelvic congestion syndrome is one of the many causes of chronic pelvic pain and is often diagnosed based on exclusion of other pathologies. Over the past decades, pelvic congestion syndrome was recognized to be a more common cause of chronic pelvic pain. Multiple diagnostic modalities including pelvic duplex ultrasonography, transvaginal ultrasonography, computed tomography, and magnetic resonance were studied. In the current literature, selective ovarian venography, an invasive imaging approach, is believed to be the gold standard for diagnosing pelvic congestion syndrome.

1 February 2018 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
RNRuhani Nanavati
Ruhani Nanavati
PJPatrick Tony Jasinski
Patrick Tony Jasinski
DADemetri Adrahtas
Demetri Adrahtas
AGAntonios Gasparis
Antonios Gasparis
NLNicos Labropoulos
Nicos Labropoulos

1 October 2017 in AORTA
Verified
Journal Article
Open access
PJPatrick Tony Jasinski
Patrick Tony Jasinski
NLNicos Labropoulos
Nicos Labropoulos
OCOlympia Christoforatos
Olympia Christoforatos
ATAPOSTOLOS TASSIOPOULOS
APOSTOLOS TASSIOPOULOS
Objective: The purpose of this study was to evaluate potential factors affecting patient non-compliance after endovascular aneurysm repair. Method: We performed a retrospective review of patients undergoing elective or emergency endovascular repair for thoracic, abdominal aorta, or iliac artery aneurysm at a single institution from November 2007 to March 2014. Compliance to follow-up at 1, 6, and 12 months was assessed. Factors evaluated included patient demographics, size of aneurysm, distance between the patient’s residence and outpatient clinic, urgency of surgery, and time of year in which the follow-up visits were scheduled. Results: During the study period, 205 patients (75% male and 25% female) fulfilled the inclusion criteria. One-month mortality was 1.1% for elective procedures and 16.1% for emergency procedures (p = 0.001). Overall mortality at 12 months was 6.3% and 32.3% for elective and emergency procedures, respectively (p = 0.0002). Highest compliance was observed at 1 month, with 184 patients (93%) attending. A significant decrease was seen at 6 (n = 102, 54%) and 12 (n = 89, 48%) months. At the 12-month mark, a larger proportion of minority patients were non-compliant compared with Caucasian patients. Confounders for non-compliance were analyzed using multivariate analysis, and statistical significance was found for widowed marital status (p = 0.008), travel distance >25 miles to the outpatient clinic (p = 0.032), and emergency repair of aneurysms (p = 0.022). Conclusion: Despite emphasizing the importance of follow-up after endovascular aortic procedures, almost half of the treated patients were non-compliant. Our study identified travel distance, marital status, and urgency of surgery as factors that may affect patients’ compliance to scheduled follow-up visits.

1 October 2016 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
DADemetri Adrahtas
Demetri Adrahtas
PJPatrick Tony Jasinski
Patrick Tony Jasinski
GKGeorge Koullias
George Koullias
DFDavid Fiorella
David Fiorella
ATApostolos K. Tassiopoulos
Apostolos K. Tassiopoulos

15 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IYIvan Ye
Ivan Ye
SGStefanos Giannopoulos
Stefanos Giannopoulos
AKAngela A. Kokkosis
Angela A. Kokkosis
PJPatrick Tony Jasinski
Patrick Tony Jasinski
NLNicos Labropoulos
Nicos Labropoulos
Background/Objectives: Calcified atherosclerotic disease of the common femoral artery (CFA) is a unique therapeutic challenge. Although endarterectomy has been the gold standard for CFA disease treatment, the evolution of endovascular techniques has led to increasing interest in minimally invasive alternatives to open surgery. Intravascular lithotripsy (IVL) offers calcium modification, facilitating vessel compliance and enhancing the effect of adjunctive therapies. Methods: A systematic review of current literature was conducted to summarize data on clinical outcomes and perioperative complications of IVL for the treatment of calcified CFA disease. Eligible studies up to July 2025 were included. Demographics, procedural and follow-up data were extracted and analyzed. Results: A total of 304 patients across 9 studies were included. The majority of the patients were males (68%) with hypertension (88%), dyslipidemia (75%) and smoking history (65%). Of the included patients, 56% had chronic limb-threatening ischemia (CLTI), with a previous intervention reported in about one-third of them. Additional calcium-modifying technology was used at the discretion of the operator in 11% of cases. The overall dissection rate was 2% (95% confidence interval (CI): 0–6%) with only five cases having flow-limiting dissections. Stenting rate was 3% (95% CI: 0–11%). No perforations or distal embolization events were reported by the rest of the studies apart from one study that had one such case. The overall periprocedural complication rate was 5% (95% CI: 0–13%). The 12-month target lesion revascularization (TLR) rate was 9% (95% CI: 3–18%). Conclusions: IVL could be a safe alternative endovascular option to open repair for treating calcified CFA disease with low rates of procedural complications. Further studies are needed to clarify IVL’s role in clinical practice, particularly for patients who are poor candidates for open surgery.

1 November 2020 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ESEdvard Skripochnik
Edvard Skripochnik
MBMohsen Bannazadeh
Mohsen Bannazadeh
PJPatrick Tony Jasinski
Patrick Tony Jasinski
SLShang A. Loh
Shang A. Loh